Group 1 - The core viewpoint of the article is that Brainstorm Cell Therapeutics Inc. (06681) experienced a significant drop in stock price following the announcement of a share placement [1] - The company plans to issue 92 million shares, which represents approximately 6.77% of the enlarged share capital [1] - The placement price is set at HKD 5.6 per share, reflecting a discount of about 12.09% compared to the closing price of HKD 6.37 on January 22 [1] Group 2 - The total funds raised from the share placement are expected to be HKD 515 million, with a net amount of approximately HKD 501 million [1] - About 50% of the proceeds will be allocated to research and development initiatives [1] - Approximately 30% of the funds will be used for domestic and international market development, while 10% will be designated for strategic investments and acquisitions, and the remaining 10% will be used for general corporate operational expenses [1]
港股异动 | 脑动极光-B(06681)低开逾6% 拟折让约12%先旧后新配股 净筹约5.01亿港元